Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish ...

A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...

The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.

A team of cancer biologists led by Princeton’s Yibin Kang has resolved a confounding paradox about retinoids and cancer cells ...

The decision to discontinue further clinical development of Acasunlimab does not impact Genmab’s full‑year 2025 financial ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Global cancer cases have surged dramatically, doubling since 1990 and reaching 18.5 million new diagnoses in 2023. Deaths ...

A recent study published in the medical journal Gut has revealed a novel cancer-promoting mechanism of Streptococcus ...

A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...

Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...

Cancer is becoming a global crisis shaped less by biology than by inequality, risk exposure, and access to care.